Skip to content

Contrast enhanced ultrasound of sentinel lymph nodes in breast cancer: a prospective multicenter study

Three dimensional contrast-enhanced ultrasound and three dimensional elastic imaging of sentinel lymph node and drainage path in breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037656
Enrollment
Unknown
Registered
2020-08-29
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:The remaining cases in each center are tested for the consistency rate of SLN ceUS surface localization and the diagnostic efficacy of SLN CEUS.The intraoperative dissection of lymphatic
Index test:Thecases&#32
in&#32
for&#32
the&#32
rate&#32
of&#32
SLN&#32
ceUS&#32
and&#32
diagnostic&#32

Sponsors

SIchuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients older than 18 years old; 2. Patients with carcinoma in situ and early invasive breast cancer; 3. The patients without enlargement of axillary lymph nodes; 4. The patients who will be treated with SLNB; 5. Patients who voluntarily sign informed consent of new technology.

Exclusion criteria

Exclusion criteria: 1. Patients during pregnancy / lactation; inflammatory breast cancer; 2; 2. Patients with positive axillary lymph nodes in clinical examination; 3. Patients who have received chemotherapy or radiotherapy; 4. Patients with history of breast surgery or plastic surgery; 5. Patients with a history of severe cardiovascular, respiratory and immune system diseases; 6. Patients with severe allergy to contrast media; 7. Patients with severe coagulation disorders.

Design outcomes

Primary

MeasureTime frame
enhancement pattern;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
location;

Countries

China

Contacts

Public ContactMan Lu

SIchuan Cancer Hospital

graceof@163.com+86 18908190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026